<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Weatherall Inst of Molecular Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AE2DBF6C-CB0D-4F16-A102-65A36D417C7C"><gtr:id>AE2DBF6C-CB0D-4F16-A102-65A36D417C7C</gtr:id><gtr:firstName>Jim</gtr:firstName><gtr:otherNames>Raymond</gtr:otherNames><gtr:surname>Hughes</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D6784BA3-960E-40CB-8663-A597913E4CF5"><gtr:id>D6784BA3-960E-40CB-8663-A597913E4CF5</gtr:id><gtr:firstName>D</gtr:firstName><gtr:surname>Higgs</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/09A9FEAD-5AE9-49A9-9D1E-38BD7E6CBCD9"><gtr:id>09A9FEAD-5AE9-49A9-9D1E-38BD7E6CBCD9</gtr:id><gtr:firstName>Sara</gtr:firstName><gtr:surname>De Ornellas</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4BA87ACF-0A01-4633-9FC2-9894A8502C5E"><gtr:id>4BA87ACF-0A01-4633-9FC2-9894A8502C5E</gtr:id><gtr:firstName>Veronica</gtr:firstName><gtr:otherNames>Jennifer</gtr:otherNames><gtr:surname>Buckle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E3462407-7311-487B-B69E-DD0CB55A2E82"><gtr:id>E3462407-7311-487B-B69E-DD0CB55A2E82</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FN00969X%2F1"><gtr:id>37715543-CBB0-4482-A885-425AFF22B4F2</gtr:id><gtr:title>Three-dimensional interrogation of gene regulation using next generation chromatin conformation capture and super-resolution imaging.</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/N00969X/1</gtr:grantReference><gtr:abstractText>To form the cells and tissues that make up our bodies requires exquisite control of the activity of our genes. The protein products of genes form the functional and structural components of our cells. Gene expression is controlled by a subgroup of proteins called transcription factors which bind specific sequences in our DNA (also called the &amp;quot;genome&amp;quot;). If this control is altered by sequence changes in the genome then the correct function of our cells is affected and can lead to disease: the particular disease or diseases depend on the types of cells affected. Scientists have become very good at finding the ~ 2% of our DNA that encodes for protein, however it has become clear that other parts of our genome (called regulatory elements) play a critical role in controlling our genes.

Regulatory elements are scattered throughout the genome and novel methods that identify such elements show that it is very difficult to understand which gene they control as they do not necessarily control nearby genes, but may affect quite distant genes. A technique called chromosome conformation capture can link regulatory elements to the genes they control by mapping their physical interactions, which are necessary for their activity, but this still does not explain why certain elements can contact and regulate some specific genes but not others. This is an important question because changes in the genome sequence can prevent regulatory elements talking to the correct genes or cause them to talk to the wrong genes with very damaging consequences. The mechanism that makes these interactions specific is unknown, but is thought to be due to the three dimensional arrangement of the genome in the nucleus. The work in this proposal adapts technologies developed by a collaboration between molecular biologists, chemists and computational scientists to visualize these interactions in 3D to understand how certain regulatory elements work with specific genes and how changes in the genome can alter this and cause disease.</gtr:abstractText><gtr:technicalSummary>Next Generation Sequencing has allowed us to investigate the structure and function of the genome at unprecedented detail. In particular, chromatin accessibility assays (DNAse-seq and ATAC-seq) produce comprehensive maps of the active regions of the genome and ChIP-seq allows sub-classification by chromatin signature which infers potential function. This has revealed an unsuspected level of complexity in the regulatory landscape of the genome with estimates of ~ 2M potential regulatory elements to control ~20,000 genes. GWAS studies have mapped the majority of disease susceptibility variants to the non-coding portion of the genome suggesting that regulatory elements may be their major targets. However finding which genes these regulatory elements are controlling and how this is achieved is a major challenge, mainly due to the unpredictability of both their number and distribution around their cognate genes. It has been shown that although these elements affect multiple genes, they may &amp;quot;ignore&amp;quot; neighbouring genes in favour of more distal genes. Chromosome conformation capture-based technologies link regulatory elements and genes via their physical interaction, but do not explain why some interactions are favoured and others prevented. As the physical interactions of these elements are thought to be required for their function, this represents a fundamental mechanism for specificity and selectivity. Such interactions, in turn, are likely related to the overall 3D structure of the genome. As small changes in non-coding sequence can have major effect on gene expression, and considering the amount of observed genome variation, it is essential to understand the mechanisms by which regulatory elements work. We propose to develop new technologies to visualize specific regulatory interactions at unprecedented levels of sensitivity and resolution, so that regulatory elements can be seen interacting within the context of the surrounding chromosomal landscape.</gtr:technicalSummary><gtr:potentialImpactText>Beneficiaries of this research will be:
1. Research scientists in academia who are working to develop a better understanding of biology in healthy cells and organisms.
2. Biomedical scientists in academia and industry who are endeavouring to understand the biological processes that occur in the development and progression of human diseases.
3. In particular the project will train a highly skilled postdoctoral researcher who will develop new inter-disciplinary skills.
4. Scientists in the pharmaceutical and biotech industries who are working in discovery biology to determine new targets for diagnostics and therapy in a wide range of diseases.
5. Companies that manufacture and supply oligonucleotide probes to academia and industry for use in the above applications.
6. The UK economy through pharmaceutical and industrial development enhancing business revenue and innovative capacity.
7. The general public who could benefit from new and improved diagnostics and therapies.
8. The general public in gaining knowledge from the modelling and visualisation outcomes proposed.
9. Schools and colleges through outreach activities.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>382297</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Chemistry and imaging</gtr:description><gtr:id>46144232-2CD7-45A9-9A42-A279A787B535</gtr:id><gtr:impact>We submitted and were awarded an MRC project Grant to further this collaboration</gtr:impact><gtr:outcomeId>56dd994e00dd06.54605903-1</gtr:outcomeId><gtr:partnerContribution>As PI on the grant I coordinate the collaboration and bring our bioinformatic and molecular skills</gtr:partnerContribution><gtr:piContribution>This collaboration brought together a multidisciplinary team or molecular biologists, microscopy experts and chemistry to generate synthetic probes for DNA capture and imaging</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Thought leader Ship article covering our research</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E004A33A-C828-4702-AB36-75263449E97B</gtr:id><gtr:impact>We were the subject of and interviewed for an article for Research Features covering thought leadership.</gtr:impact><gtr:outcomeId>58c810686faea6.99281889</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://cdn.researchfeatures.com/3d_issues/issue104/index.html</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Scientist Live 2017</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>93CD9F3A-311C-44BE-B4E8-FDA6E2421C35</gtr:id><gtr:impact>We organised and presented an interactive exhibit on the how the 3-Dimension Genome is linked to common human disease. At the center of this was a specific implementation of our CSynth tool for structural visualisation of genome structure http://www.csynth.org/.</gtr:impact><gtr:outcomeId>58c80f33369986.16263670</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://live.newscientist.com/exhibitors/weatherall-institute-of-molecular-medicine/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>382298</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N00969X/1</gtr:fundingRef><gtr:id>9CF1C4BE-A47D-46D2-A163-AD0F48DD665C</gtr:id><gtr:outcomeId>58c12cc2675d53.58583371</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The IP covers the Next Generation Capture-C method for massively multiplexed 3C analysis of genome interactions.</gtr:description><gtr:grantRef>MR/N00969X/1</gtr:grantRef><gtr:id>AC63109C-21B4-44CF-A6CB-F9842FF69BDF</gtr:id><gtr:impact>None so far</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c12dedc37ce4.00608244</gtr:outcomeId><gtr:patentId>PCT/GB2016/053314</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>NG Capture C</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A vast more sensitive version of the original Capture-C assay.</gtr:description><gtr:id>A2B091DD-2B4E-4478-A9BE-D60BF8E0EC06</gtr:id><gtr:impact>This approach is now being used world-wide to interrogate question of gene regulation and the effect of sequence changes associated with common disease.</gtr:impact><gtr:outcomeId>58c8152f92b016.52095981</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Next Generation Capture-C</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>654538B1-6868-40D1-9218-8A0DF891DD15</gtr:id><gtr:title>Capture-C reveals preformed chromatin interactions between HIF-binding sites and distant promoters.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c9f133a0e8ba36b1df6bc475074ed92"><gtr:id>6c9f133a0e8ba36b1df6bc475074ed92</gtr:id><gtr:otherNames>Platt JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>58beba6f02f040.34787031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>788215D1-9CE4-46E7-B5C7-14D41AFFF4A6</gtr:id><gtr:title>Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6df6a39e43b507b1d559bb73d2f82d"><gtr:id>7b6df6a39e43b507b1d559bb73d2f82d</gtr:id><gtr:otherNames>Ooi WF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58beba6e9e87c9.62081886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71EAE380-21E5-4AB6-9A20-0458D04E5AD3</gtr:id><gtr:title>Sasquatch: predicting the impact of regulatory SNPs on transcription factor binding from cell- and tissue-specific DNase footprints.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33af11dc5da0f24c16179ff924dff6bf"><gtr:id>33af11dc5da0f24c16179ff924dff6bf</gtr:id><gtr:otherNames>Schwessinger R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>5a6f2eb3b1b008.49877943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0E2C7A2-B481-4B56-BC6A-D6B66655F0BC</gtr:id><gtr:title>Genetic dissection of the a-globin super-enhancer in vivo.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4372a7f2d5ea1d6313b49e5c539a538"><gtr:id>f4372a7f2d5ea1d6313b49e5c539a538</gtr:id><gtr:otherNames>Hay D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58beba6f2aa4b2.48571467</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58F456E2-D899-4772-B224-A84AA88523C4</gtr:id><gtr:title>MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27&amp;nbsp;acetylation.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3884bf14da03fa4c535aae5731896efe"><gtr:id>3884bf14da03fa4c535aae5731896efe</gtr:id><gtr:otherNames>Godfrey L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn><gtr:outcomeId>58beba6e725467.86929692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB235C4F-26A6-49D3-94FF-9F2E41EA4F15</gtr:id><gtr:title>Unlinking an lncRNA from Its Associated cis Element.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cde1bf1e8b62d983171263312e7448a"><gtr:id>0cde1bf1e8b62d983171263312e7448a</gtr:id><gtr:otherNames>Paralkar VR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>58bebae9c3b4c3.27011591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5C30FDB-849C-48F2-8625-6BE5B7C00C4B</gtr:id><gtr:title>Predicting the three-dimensional folding of cis-regulatory regions in mammalian genomes using bioinformatic data and polymer models.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d87292c502efcf92b713683b2fa01cbc"><gtr:id>d87292c502efcf92b713683b2fa01cbc</gtr:id><gtr:otherNames>Brackley CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58bebaea082058.10000711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAA47D71-3DF8-42F3-9F8A-2240B50B2105</gtr:id><gtr:title>Low-input Capture-C: A Chromosome Conformation Capture Assay to Analyze Chromatin Architecture in Small Numbers of Cells.</gtr:title><gtr:parentPublicationTitle>Bio-protocol</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76bdd222d2fda6fbb041ce1329f33732"><gtr:id>76bdd222d2fda6fbb041ce1329f33732</gtr:id><gtr:otherNames>Oudelaar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2331-8325</gtr:issn><gtr:outcomeId>5a6f2f102d23f5.32260805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32D3D4E2-9A03-401F-87FA-5CBA4E1E8C5F</gtr:id><gtr:title>Robust detection of chromosomal interactions from small numbers of cells using low-input Capture-C.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76bdd222d2fda6fbb041ce1329f33732"><gtr:id>76bdd222d2fda6fbb041ce1329f33732</gtr:id><gtr:otherNames>Oudelaar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a6f2ecd45f113.75868832</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/N00969X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>